Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Quarter ended June 30, 2016 (Q1 FY17)
Filing Date: July 27, 2016
This filing discloses the results of operations and financial condition for the quarter ended June 30, 2016. The company announced these results on July 26, 2016, under International Financial Reporting Standards (IFRS). Unaudited standalone and consolidated financial results under Indian Accounting Standards (Ind AS) are also referenced as attached exhibits.
Key Financial Metrics
The provided filing text serves as a cover document referencing attached exhibits (99.1, 99.2, 99.3) containing the detailed financial data. The text itself does not provide clear values for the following metrics:
- Revenue
- Profit (Net Income)
- Cash Flow
- Margins
- Debt Levels
- Liquidity Ratios
Material Changes
The filing text does not contain specific numerical comparisons or descriptions of material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) and financial statements (Exhibits 99.2 and 99.3) for year-over-year or quarter-over-quarter analysis.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, contingencies, or unusual items for the period. It strictly confirms the availability of the results on the company website (www.drreddys.com) and within the attached exhibits.
Investor Verification Checklist
- Verify the specific revenue and profit figures in the attached Press Release (Exhibit 99.1).
- Review the Ind AS Unaudited Consolidated Financial Results (Exhibit 99.3) for a complete view of the group's performance.
- Check the company website for the full text of the July 26, 2016 announcement to understand management's commentary on the results.
- Confirm if there are any material differences between the IFRS results and the Ind AS results provided in the exhibits.